Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?

Cussenot, Olivier; Cancel-Tassin, Geraldine; Rao, Srinivasa R; Woodcock, Dan J; Lamb, Alastair D; Mills, Ian G; Hamdy, Freddie C

Cussenot, Olivier; Cancel-Tassin, Geraldine; Rao, Srinivasa R; Woodcock, Dan J; Lamb, Alastair D; Mills, Ian G; Hamdy, Freddie C.

Afiliação

Cussenot O; Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
Cancel-Tassin G; GRC 5 Predictive Onco-Urology, Sorbonne University, Paris, France.
Rao SR; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Woodcock DJ; Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
Lamb AD; GRC 5 Predictive Onco-Urology, Sorbonne University, Paris, France.
Mills IG; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

BJU Int ; 132(5): 472-484, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37410655

Palavras-chave

clinical practice; genetics; germline mutation; prostate cancer; somatic biomarker

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google